PTH and bortezomib suppress growth of primary human myeloma through increased bone formation in vivo.

被引：0
|
作者：
Pennisi, Angela [1 ]
Ling, Wen [1 ]
Perkins, Paul [1 ]
Saha, Rinku [1 ]
Li, Xin [1 ]
Barlogie, Bart [1 ]
Tricot, Guido [1 ]
Zangari, Maurizio [1 ]
Yaccoby, Shmuel [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Theraphy, Little Rock, AR 72205 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
509
引用
收藏
页码：154A / 154A
页数：1
相关论文
共 50 条
  • [1] PTH receptor (PTH-R) mRNA expression by human bone cells in vivo.
    Moore, P
    Gokal, RG
    Freemont, AJ
    Hoyland, JA
    JOURNAL OF PATHOLOGY, 1997, 181 : A44 - A44
  • [2] The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo
    Pennisi, Angela
    Li, Xin
    Ling, Wen
    Khan, Sharmin
    Zangari, Maurizio
    Yaccoby, Shmuel
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (01) : 6 - 14
  • [3] MCR peptides suppress human lung cancer growth in vitro and in vivo.
    Radulescu, RT
    Cybon, C
    Manuilova, T
    Jaques, G
    CLINICAL CANCER RESEARCH, 2000, 6 : 4564S - 4564S
  • [4] Human Placenta-Derived Adherent Stem Cells Prevent Bone Loss and Stimulate Bone Formation in Myelomatous Bones, and Suppress Growth of Primary Multiple Myeloma
    Li, Xin
    Ling, Wen
    Pennisi, Angela
    Chen, Jianmei
    Khan, Sharmin
    Heidaran, Mohammad
    Faleck, Herbert
    Hariri, Robert
    Shaughnessy, John
    van Rhee, Frits
    Epstein, Joshua
    Barlogie, Bart
    Yaccoby, Shmuel
    BLOOD, 2008, 112 (11) : 240 - 241
  • [5] Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone
    Li, Xin
    Ling, Wen
    Pennisi, Angela
    Wang, Yuping
    Khan, Sharmin
    Heidaran, Mohammad
    Pal, Ajai
    Zhang, Xiaokui
    He, Shuyang
    Zeitlin, Andy
    Abbot, Stewart
    Faleck, Herbert
    Hariri, Robert
    Shaughnessy, John D., Jr.
    van Rhee, Frits
    Nair, Bijay
    Barlogie, Bart
    Epstein, Joshua
    Yaccoby, Shmuel
    STEM CELLS, 2011, 29 (02) : 263 - 273
  • [6] LKBα-deficient mice display increased osteoclast formation and activity and bone loss in vivo.
    Edwards, J. R.
    Connelly, L.
    Han, W.
    Dumitrescu, L. C.
    Blackwell, T. S.
    Yull, F.
    Mundy, G. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S42 - S42
  • [7] TGF-bera inhibition restores bone formation to suppress tumor growth in myeloma
    Takeuchi, K.
    Abe, M.
    Oda, A.
    Amou, H.
    Fujii, S.
    Tanaka, O.
    Hiasa, M.
    Mihara, A.
    Miki, H.
    Asano, J.
    Kagawa, K.
    Kitazoe, K.
    Hashimoto, T.
    Ozaki, S.
    Kido, S.
    Matsumoto, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 133 - 133
  • [8] IN-VITRO AND EX-VIVO EVIDENCE THAT ESTROGENS SUPPRESS INCREASED BONE-RESORPTION INDUCED BY OVARIECTOMY OR PTH STIMULATION THROUGH AN EFFECT ON OSTEOCLASTOGENESIS
    MOST, W
    SCHOT, L
    EDERVEEN, A
    VANDERWEEPALS, L
    PAPAPOULOS, S
    LOWIK, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 (10) : 1523 - 1530
  • [9] The proteasome inhibitor bortezomib affects osteoblastogenesis and bone formation in vitro and in vivo in multiple myeloma patients.
    Giuliani, Nicola
    Morandi, Francesca
    Tagliaferri, Sara
    Lazzaretti, Mirca
    Bonomini, Sabrina
    Crugnola, Monica
    Petro, Daniela
    Mancini, Cristina
    Martella, Eugenia
    Rizzoli, Vittorio
    BLOOD, 2006, 108 (11) : 154A - 154A
  • [10] Chronic exposure to platelet-derived growth factor interferes with bone formation In vivo.
    Carnes, D
    Graves, D
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 218 - 218
12345